Seizing child recieving IN treatmentTherapeutic Intranasal Drug Delivery

Needleless treatment options for medical problems

(Scroll down if the text is missing on your screen)

Why you should consider intranasal drug administration as another option for delivering medications to patients:

Acute seizures, narcotic overdose, severe hypoglycemia, procedural sedation, and acute and chronic pain control are all complex medical problems requiring multiple approaches for effective management. Intranasal (IN) drug delivery is emerging as a low-tech, inexpensive and non-invasive first line method for managing these and other medical problems.  Nasal medication delivery takes a middle path between slow onset oral medications and invasive, highly skilled delivery of intravenous medications. Medication deposited on the highly vascular nasal mucosa may be rapidly absorbed into the blood stream and cerebral spinal fluid (CSF), achieving therapeutic drug levels more quickly and predictably than oral medications while avoiding needles. This results in therapeutic drug levels and effective treatment of seizures, pain, anxiety, hypoglycemia, opiate overdose, epistaxis (bloody noses), etc without the need to give a shot or a pill. Because intra-nasal medication delivery is effective using generic medications, it is quite inexpensive, an advantage in this era of increasingly expensive medical technology. This web site offers health care and consumers information about nasal drug therapy: medical research, expert testimonial opinion and protocol suggestions. Major topics reviewed include intranasal midazolam for sedation and seizures, intranasal fentanyl and intranasal sufentanil for acute and chronic pain control, intranasal naloxone for opiate overdoses and intranasal glucagon for hypoglycemia.

Testimonial regarding importance of intranasal medication delivery as another therapeutic option:

Ray Fowler, MD; Professor of Emergency Medicine, Chief of EMS, Parkland Memorial Hospital, Dallas Texas

January 14, 2010

Dear Tim,

I am offering this little note to share with you some thoughts regarding the importance of mucosal administration in the care of our patients. It is clear to us in the fields of emergency medicine and EMS medicine that we have had a long neglected opportunity for care. You have brought this advance to the forefront. You saw clearly that through a novel yet simple idea, we could garner a new advantage that had long been missing in clinical care. Because of your insight, we can now approach many of the long‐dealt‐with dilemmas in emergency care that before often eluded us, indeed caused us to offer in many cases less than optimal care.

One important example is in the treatment of seizures. Those of us who have dealt with pediatric patients suffering from convulsions for example, in the absence of intravenous access, have been left with virtually no other alternative than the per rectum administration of diazepam to halt the seizure. You gathered the budding information in the literature and quickly adapted an invention that could simply, safely treat this difficult problem in a much more proper, much less toxic manner. This has been a great advance in the history of medicine.

Another critical area, the dilemma of “excited delirium,” presents a hazard to patient and responder alike. These patients must often be sedated to provide safety in therapy and management. The intranasal route of administration presents a fast alternative that is much less hazardous for the responding emergency provider as regards the potential for infectious disease contamination from the patient, especially in the difficult problem of the spread of viruses such as hepatitis C and HIV through needle‐stick exposure.

Finally, we all understand how important the prompt treatment of severe pain is to our patients. We now have the capability of prompt administration of fentanyl via the intranasal route and thousands of patients will no longer suffer as a result of this important medical advance.

I would close by thanking you for your contributions to medicine, Tim. You have seen clearly where others did not. Because of your persistence and your great loving heart, patients everywhere – who will never know you – are being treated promptly and humanely, for the benefit of all concerned.

Thank you for your service and dedication.

With kind regards, I am

Respectfully,

Raymond L. Fowler, MD, FACEP

Professor of Emergency Medicine

Chief of EMS Operations

Southwestern Medical Center at Dallas

Attending Emergency Medicine Faculty

Parkland Memorial Hospital

Disclaimer: The information on this web site is for educational and informational purposes only. It is not professional medical advice nor is it intended to substitute for such. Most intranasal medication usage is "off label"  (lacking FDA or other government approved indications for intranasal delivery). Clinicians should use this therapy based on patient needs and peer reviewed literature support, realizing that many commonly used medical therapies and medication uses are used "off-label."